Latest Mir-200 Stories
Cancer researchers from Rice University have deciphered the operating principles of a genetic switch that cancer cells use to decide when to metastasize and invade other parts of the body.
A small group of immune-regulating molecules, when overproduced even moderately, can trigger the blood cancers known as lymphomas.
Researchers have identified two molecules that could potentially serve as biomarkers in predicting brain metastases in patients with breast cancer.
Tumor metastasis, the ability of cancer cells to migrate from their tissue of origin and colonize elsewhere in the body, accounts for over 90% of cancer deaths.
A team of scientists, led by researchers at the University of California, San Diego School of Medicine, has shown for the first time how cancer cells control the ON/OFF switch of a program used by developing embryos to effectively metastasize in vivo, breaking free and spreading to other parts of the body, where they can proliferate and grow into secondary tumors.
Reintroducing miR-200c to triple-negative breast cancer cells makes migrating cells self-destruct
Researchers at Moffitt Cancer Center have discovered that the micro ribonucleic acid miR-214 plays a critical role in regulating ovarian cancer stem cell properties.
- The act of sweetening by admixture of some saccharine substance.